Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Triple-Blind, Placebo-Controlled, Randomized Clinical Trial of CANnabinoids for Drug Resistant Epilepsy in Adults and Children

NCT07023744 is registered in ClinicalTrials.gov with University of Manitoba as lead sponsor.

NCT NCT07023744
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07023744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Triple-Blind, Placebo-Controlled, Randomized Clinical Trial of CANnabinoids for Drug Resistant Epilepsy in Adults and Children
Lead sponsor
University of Manitoba
Phase
Phase 2
Overall status
Not yet recruiting
Start date
July 27, 2026
Completion date
March 31, 2028
Enrollment
90 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

drug resistant epilepsy